Skip to content

Research & Literature

Last updated:

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature

Visualize citation networks across 66 referenced papers

Top Authors

Top Institutions

References

  1. 1

    Steroid-induced glaucoma and childhood blindness.

    Gupta S, Shah P, Grewal S, et al.

    The British journal of ophthalmology 2015; (99(11)):1454-6 doi:10.1136/bjophthalmol-2014-306557.

    PMID: 26002945
  2. 2

    Topographic corneal changes in children with vernal keratoconjunctivitis: A report from Kathmandu, Nepal.

    Gautam V, Chaudhary M, Sharma AK, et al.

    Contact lens & anterior eye : the journal of the British Contact Lens Association 2015; (38(6)):461-5.

    PMID: 26070227
  3. 3

    Vernal Keratoconjunctivitis in Kashmir: A temperate zone.

    Sofi RA, Mufti A

    International ophthalmology 2016; (36(6)):875-879 doi:10.1007/s10792-016-0213-8.

    PMID: 26961753
  4. 4

    Effect of Allergic Diseases on Keratoconus Severity.

    Naderan M, Rajabi MT, Zarrinbakhsh P, Bakhshi A

    Ocular immunology and inflammation 2017; (25(3)):418-423 doi:10.3109/09273948.2016.1145697.

    PMID: 27014800
  5. 5

    Impact of Vernal Keratoconjunctivitis on School Children in Egypt.

    Marey HM, Mandour SS, El Morsy OA, et al.

    Seminars in ophthalmology 2017; (32(5)):543-549 doi:10.3109/08820538.2015.1123737.

    PMID: 27128625
  6. 6

    Prevalence and associated factors of vernal keratoconjunctivitis among children in Gondar city, Northwest Ethiopia.

    Hayilu D, Legesse K, Lakachew N, Asferaw M

    BMC ophthalmology 2016; (16(1)):167 doi:10.1186/s12886-016-0345-7.

    PMID: 27681885
  7. 7

    Serum Vitamin D Levels in Children with Vernal Keratoconjunctivitis.

    Bozkurt B, Artac H, Ozdemir H, et al.

    Ocular immunology and inflammation 2018; (26(3)):435-439 doi:10.1080/09273948.2016.1235714.

    PMID: 27775457
  8. 8

    Vernal shield ulcers treated with frequently installed topical cyclosporine 0.05% eyedrops.

    Westland T, Patryn EK, Nieuwendaal CP, et al.

    International ophthalmology 2018; (38(1)):363-368 doi:10.1007/s10792-016-0424-z.

    PMID: 28120172
  9. 9

    Supratarsal injection of triamcinolone for severe vernal keratoconjunctivitis in children.

    Costa AXD, Gomes JÁP, Marculino LGC, et al.

    Arquivos brasileiros de oftalmologia 2017; (80(3)):186-188 doi:10.5935/0004-2749.20170045.

    PMID: 28832741
  10. 10

    Allergic conjunctivitis: current concepts on pathogenesis and management.

    Sacchetti M, Abicca I, Bruscolini A, et al.

    Journal of biological regulators and homeostatic agents 2018; (32(1 Suppl. 1)):49-60.

    PMID: 29552874
  11. 11

    Recalcitrant Atopic Keratoconjunctivitis in Children: A Case Report and Literature Review.

    Li J, Luo X, Ke H, Liang L

    Pediatrics 2018; (141(Suppl 5)):S470-S474 doi:10.1542/peds.2016-2069.

    PMID: 29610174
  12. 12

    Prevalence of vernal keratoconjunctivitis and its associated factors among children in Gambella town, southwest Ethiopia, June 2018.

    Alemayehu AM, Yibekal BT, Fekadu SA

    PloS one 2019; (14(4)):e0215528 doi:10.1371/journal.pone.0215528.

    PMID: 30998721
  13. 13

    Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis.

    Senthil S, Thakur M, Rao HL, et al.

    The British journal of ophthalmology 2020; (104(2)):265-269 doi:10.1136/bjophthalmol-2019-313988.

    PMID: 31055451
  14. 14

    Vernal Keratoconjunctivitis: an update focused on clinical grading system.

    Zicari AM, Capata G, Nebbioso M, et al.

    Italian journal of pediatrics 2019; (45(1)):64 doi:10.1186/s13052-019-0656-4.

    PMID: 31113464
  15. 15

    Pathogenesis and complications of chronic eye rubbing in ocular allergy.

    Ben-Eli H, Erdinest N, Solomon A

    Current opinion in allergy and clinical immunology 2019; (19(5)):526-534 doi:10.1097/ACI.0000000000000571.

    PMID: 31343437
  16. 16

    Pattern of steroid misuse in vernal keratoconjunctivitis resulting in steroid induced glaucoma and visual disability in Indian rural population: An important public health problem in pediatric age group.

    Sen P, Jain S, Mohan A, et al.

    Indian journal of ophthalmology 2019; (67(10)):1650-1655 doi:10.4103/ijo.IJO_2143_18.

    PMID: 31546501
  17. 17

    Gonioscopy-assisted Transluminal Trabeculotomy in a Pediatric Patient With Steroid-induced Glaucoma.

    Hopen ML, Gallardo MJ, Grover D

    Journal of glaucoma 2019; (28(10)):e156-e158 doi:10.1097/IJG.0000000000001326.

    PMID: 31574020
  18. 18

    Clinical characteristics and outcomes of ocular allergy in Thai children.

    Jongvanitpak R, Vichyanond P, Jirapongsananuruk O, et al.

    Asian Pacific journal of allergy and immunology 2022; (40(4)):407-413 doi:10.12932/AP-160519-0564.

    PMID: 32061246
  19. 19

    Corneal Microstructural Changes by Confocal Microscopy in Vernal Keratoconjunctivitis Patients Treated with Topical Cyclosporine.

    Modugno RL, Scalora T, Bonaldo A, et al.

    Ocular immunology and inflammation 2021; (29(7-8)):1599-1605 doi:10.1080/09273948.2020.1745243.

    PMID: 32275180
  20. 20

    Ocular allergy test and biomarkers on the ocular surface: Clinical test for evaluating the ocular surface condition in allergic conjunctival diseases.

    Shoji J

    Allergology international : official journal of the Japanese Society of Allergology 2020; (69(4)):496-504 doi:10.1016/j.alit.2020.05.003.

    PMID: 32563624
  21. 21

    Adult vernal keratoconjunctivitis.

    Di Zazzo A, Bonini S, Fernandes M

    Current opinion in allergy and clinical immunology 2020; (20(5)):501-506 doi:10.1097/ACI.0000000000000672.

    PMID: 32675480
  22. 22

    Vernal Keratoconjunctivitis: A Case of Anti-IgE Treatment with Short-Lasting Remission.

    Gatta A, Della Valle L, Farinelli A, et al.

    Case reports in ophthalmology 2020; (11(2)):268-275 doi:10.1159/000508031.

    PMID: 32774291
  23. 23

    Management of corneal complications in vernal keratoconjunctivitis: A review.

    Feizi S, Javadi MA, Alemzadeh-Ansari M, et al.

    The ocular surface 2021; (19()):282-289 doi:10.1016/j.jtos.2020.10.005.

    PMID: 33148465
  24. 24

    Japanese guidelines for allergic conjunctival diseases 2020.

    Miyazaki D, Takamura E, Uchio E, et al.

    Allergology international : official journal of the Japanese Society of Allergology 2020; (69(3)):346-355 doi:10.1016/j.alit.2020.03.005.

    PMID: 33211650
  25. 25

    Efficacy of 2% Rebamipide Suspension for Vernal Keratoconjunctivitis: A Clinical Comparison with Topical Immune Modulators Cyclosporine and Tacrolimus.

    Malhotra C, Singh H, Jain AK, et al.

    Ocular immunology and inflammation 2022; (30(5)):1083-1091 doi:10.1080/09273948.2020.1867870.

    PMID: 33764241
  26. 26

    Comparative efficacy of medical treatments for vernal keratoconjunctivitis in children and young adults: a systematic review with network meta-analyses.

    Rasmussen MLR, Schou MG, Bach-Holm D, et al.

    Acta ophthalmologica 2022; (100(1)):35-44 doi:10.1111/aos.14858.

    PMID: 33779061
  27. 27

    Health-related quality of life in children at the diagnosis of Vernal Keratoconjunctivitis.

    Artesani MC, Esposito M, Sacchetti M, et al.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2021; (32(6)):1271-1277 doi:10.1111/pai.13520.

    PMID: 33877712
  28. 28

    Association of Allergic Conjunctivitis With Health-Related Quality of Life in Children and Their Parents.

    Zhang SY, Li J, Liu R, et al.

    JAMA ophthalmology 2021; (139(8)):830-837 doi:10.1001/jamaophthalmol.2021.1708.

    PMID: 34110380
  29. 29

    Knowledge, Attitude, and Practice Among Caregivers of Children With Vernal Keratoconjunctivitis in a Tertiary Care Pediatric Hospital.

    Wadhwani M, Kursange S, Chopra K, et al.

    Journal of pediatric ophthalmology and strabismus 2021; (58(6)):390-395 doi:10.3928/01913913-20210426-02.

    PMID: 34228566
  30. 30

    Vernal keratoconjunctivitis and keratoconus.

    Wajnsztajn D, Solomon A

    Current opinion in allergy and clinical immunology 2021; (21(5)):507-514 doi:10.1097/ACI.0000000000000765.

    PMID: 34269743
  31. 31

    Immunopharmacology in Vernal Keratoconjunctivitis: Current and Future Perspectives.

    Chigbu DI, Labib BA

    Pharmaceuticals (Basel, Switzerland) 2021; (14(7)) doi:10.3390/ph14070658.

    PMID: 34358085
  32. 32

    A Case of Shield Ulcer Due to Vernal Keratoconjunctivitis.

    Özkaya D, Usta G, Karaca U

    Iranian journal of allergy, asthma, and immunology 2021; (20(4)):505-508.

    PMID: 34418905
  33. 33

    Sensitization and Clinical Characteristics of Congolese Children with Vernal Keratoconjunctivitis in Kinshasa.

    Muamba Nkashama L, Kayembe Lubeji D, Mwanza Kasongo JC, et al.

    Ocular immunology and inflammation 2023; (31(1)):15-20 doi:10.1080/09273948.2021.1976217.

    PMID: 34582304
  34. 34

    Understanding Vernal Keratoconjunctivitis: Beyond Allergic Mechanisms.

    Sacchetti M, Plateroti R, Bruscolini A, et al.

    Life (Basel, Switzerland) 2021; (11(10)) doi:10.3390/life11101012.

    PMID: 34685384
  35. 35

    Giant Papilla Prolapse from the Upper Tarsal Conjunctiva in a 3-year-old Child: A Case Presentation and a Brief Literature Review.

    Kurtul BE, Koca S

    Beyoglu eye journal 2021; (6(1)):70-73 doi:10.14744/bej.2021.65807.

    PMID: 35005496
  36. 36

    Efficacy and Satisfaction of Cyclosporine 0.1% in Patients with Vernal Keratoconjunctivitis.

    Salami E, Righetti G, Cavarzeran F, Leonardi A

    Ocular immunology and inflammation 2023; (31(9)):1870-1872 doi:10.1080/09273948.2022.2103833.

    PMID: 35914313
  37. 37

    Diagnosis, Management, and Treatment of Vernal Keratoconjunctivitis in Asia: Recommendations From the Management of Vernal Keratoconjunctivitis in Asia Expert Working Group.

    Mehta JS, Chen WL, Cheng ACK, et al.

    Frontiers in medicine 2022; (9()):882240 doi:10.3389/fmed.2022.882240.

    PMID: 35979210
  38. 38

    The effect of COVID-19 imposed lockdown on Italian children with Vernal Keratoconjunctivitis.

    Artesani MC, Esposito M, Sacchetti M, et al.

    The World Allergy Organization journal 2022; (15(10)):100701 doi:10.1016/j.waojou.2022.100701.

    PMID: 36117875
  39. 39

    Practice patterns and opinions in the treatment of allergic eye disease: A survey among Indian ophthalmologists.

    Priyadarshini SR, Das S

    Indian journal of ophthalmology 2023; (71(1)):80-85 doi:10.4103/ijo.IJO_1360_22.

    PMID: 36588213
  40. 40

    Demographic and clinical characteristics of childhood and adult onset Vernal Keratoconjunctivitis in a tertiary care center during Covid pandemic: A prospective study.

    Singh A, Rana J, Kataria S, et al.

    Romanian journal of ophthalmology 2022; (66(4)):344-351 doi:10.22336/rjo.2022.61.

    PMID: 36589333
  41. 41

    The association between keratoconus and allergic eye diseases: A systematic review and meta-analysis.

    Seth I, Bulloch G, Vine M, et al.

    Clinical & experimental ophthalmology 2023; (51(4)):O1-O16 doi:10.1111/ceo.14215.

    PMID: 36882200
  42. 42

    Characteristics of Vernal Keratoconjunctivitis in Lhasa: A Single-Center, Observational Study.

    Yang S, Zhang W, Qiong Da CR, Wu Y

    Ocular immunology and inflammation 2024; (32(5)):648-651 doi:10.1080/09273948.2023.2190804.

    PMID: 36989072
  43. 43

    Corneal topometric indices and proclivity toward corneal ectasia in vernal keratoconjunctivitis.

    Yilmaz YC, Ipek SC, Gobeka HH

    Journal francais d'ophtalmologie 2024; (47(1)):103792 doi:10.1016/j.jfo.2023.01.010.

    PMID: 37087321
  44. 44

    Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab.

    Doan S, Papadopoulos NG, Lee JK, et al.

    The World Allergy Organization journal 2023; (16(6)):100788 doi:10.1016/j.waojou.2023.100788.

    PMID: 37389200
  45. 45

    Surgical Treatment of Corneal Shield Ulcer in Vernal Keratoconjunctivitis: A Systematic Review.

    Azizi S, Subhi Y, Rasmussen MLR

    Journal of personalized medicine 2023; (13(7)) doi:10.3390/jpm13071092.

    PMID: 37511705
  46. 46

    Vernal Keratoconjunctivitis: A Systematic Review.

    Bruschi G, Ghiglioni DG, Cozzi L, et al.

    Clinical reviews in allergy & immunology 2023; (65(2)):277-329 doi:10.1007/s12016-023-08970-4.

    PMID: 37658939
  47. 47

    Two cases of unilateral limbal Vernal keratoconjunctivitis in the same family: first case report.

    Michieletto P, Sica A, Barbi E, Pensiero S

    Frontiers in pediatrics 2023; (11()):1237760 doi:10.3389/fped.2023.1237760.

    PMID: 37849497
  48. 48

    Management of vernal keratoconjunctivitis: Navigating a changing treatment landscape.

    Ali A, Bielory L, Dotchin S, et al.

    Survey of ophthalmology 2024; (69(2)):265-278 doi:10.1016/j.survophthal.2023.10.008.

    PMID: 37890678
  49. 49

    Classification of Subtypes of Vernal Keratoconjunctivitis by Cluster Analysis Based on Clinical Features.

    Fujita H, Ueno T, Suzuki S, et al.

    Clinical ophthalmology (Auckland, N.Z.) 2023; (17()):3271-3279 doi:10.2147/OPTH.S431798.

    PMID: 37927573
  50. 50

    A Patient-Centered Approach to Vernal Keratoconjunctivitis (VKC): A Podcast.

    Larsen AC, Rasmussen MLR

    Ophthalmology and therapy 2024; (13(5)):1061-1069 doi:10.1007/s40123-024-00909-y.

    PMID: 38436902
  51. 51

    Prevalence and risk factors of Vernal Keratoconjunctivitis among a Ghanaian clinical cohort: A case-control study.

    Kyei S, Nkansah M, Asiedu K, et al.

    Health science reports 2024; (7(3)):e1957 doi:10.1002/hsr2.1957.

    PMID: 38440260
  52. 52

    Vernal Keratoconjunctivitis: Immunopathological Insights and Therapeutic Applications of Immunomodulators.

    Hehar NK, Chigbu DI

    Life (Basel, Switzerland) 2024; (14(3)) doi:10.3390/life14030361.

    PMID: 38541686
  53. 53

    A Case of Refractory Vernal Keratoconjunctivitis Showing Improvement after the Administration of Upadacitinib for the Treatment of Atopic Dermatitis.

    Mima Y, Tsutsumi E, Ohtsuka T, et al.

    Diagnostics (Basel, Switzerland) 2024; (14(12)) doi:10.3390/diagnostics14121272.

    PMID: 38928687
  54. 54

    Vernal keratoconjunctivitis in adults: a narrative review of prevalence, pathogenesis, and management.

    Di Zazzo A, Zhu AY, Nischal K, Fung SSM

    Frontiers in ophthalmology 2024; (4()):1328953 doi:10.3389/fopht.2024.1328953.

    PMID: 38984145
  55. 55

    Topical Tacrolimus in Anterior Segment Disorders in Ophthalmology: A Review.

    Alrashidi SH

    Romanian journal of ophthalmology 2024; (68(2)):92-98 doi:10.22336/rjo.2024.19.

    PMID: 39006333
  56. 56

    Health-related Quality of Life in Children with Vernal Keratoconjunctivitis in Malaysia.

    Khairil-Ridzwan KK, Lai YS, Fiona CLM, Shatriah I

    Korean journal of ophthalmology : KJO 2024; (38(5)):364-374 doi:10.3341/kjo.2024.0048.

    PMID: 39155135
  57. 57

    Long-Term Observation of Prognostic Factors and Clinical Outcome of Vernal Keratoconjunctivitis in Childhood.

    Shimokawa A, Ikeda A, Harada K, et al.

    Clinical ophthalmology (Auckland, N.Z.) 2024; (18()):2339-2347 doi:10.2147/OPTH.S472826.

    PMID: 39193318
  58. 58

    Seeing eye to eye: a modified Delphi method-based multidisciplinary expert consensus on the diagnosis and treatment of vernal keratoconjunctivitis.

    Ghiglioni DG, Bruschi G, Chiappini E, et al.

    European journal of pediatrics 2024; (183(11)):5053-5061 doi:10.1007/s00431-024-05776-0.

    PMID: 39325215
  59. 59

    Efficacy of Epinastine Eyelid Cream in Pediatric Vernal Keratoconjunctivitis: A Case Report.

    Hashida N, Hirose R, Shiozaki D, Mamoto Y

    Cureus 2024; (16(11)):e74268 doi:10.7759/cureus.74268.

    PMID: 39717308
  60. 60

    Insights from 1096 clinical cases: pioneering a universal grading system for vernal keratoconjunctivitis management.

    Chandrasekar A, Agarwal S, Chauhan G, et al.

    The British journal of ophthalmology 2025; (109(7)):735-741 doi:10.1136/bjo-2024-325762.

    PMID: 39880668
  61. 61

    Steroid-Induced Ocular Hypertension in Children: A Review on Risk Factors.

    Lacau S, Marin A, Bitrian E

    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2025; (41(6)):305-313 doi:10.1089/jop.2025.0024.

    PMID: 40359125
  62. 62

    Vernal Keratoconjunctivitis: Impact on Children.

    Gu SZ, Trief D

    Eye & contact lens 2025; (51(7)):296-299 doi:10.1097/ICL.0000000000001181.

    PMID: 40472188
  63. 63

    The psychological impact of vernal keratoconjunctivitis on families: An investigation on quality of life and psychological wellbeing.

    Natali L, Cardi V, Cavarzeran F, Leonardi A

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2025; (36(7)):e70141 doi:10.1111/pai.70141.

    PMID: 40611492
  64. 64

    Shield ulcer in keratoconus in the absence of atopic or vernal kerato-conjunctivitis.

    Niestrata M, Kohli S, Saleki M, Ashena Z

    GMS ophthalmology cases 2025; (15()):Doc05 doi:10.3205/oc000253.

    PMID: 40708598
  65. 65

    Surgical Management of Corneal Sequelae of Vernal Keratoconjunctivitis.

    Sharma S, Dandekar P, Nagpal V, et al.

    Seminars in ophthalmology 2026; (41(1)):174-183 doi:10.1080/08820538.2025.2551061.

    PMID: 40884264
  66. 66

    Risk Factors Associated With Steroid-Induced Ocular Hypertension and Glaucoma in Patients With Vernal Keratoconjunctivitis in a North Indian Population: A Multicenter Study.

    Dubey S, Shakya R, Pegu J, et al.

    Cureus 2025; (17(8)):e89972 doi:10.7759/cureus.89972.

    PMID: 40951145